Clinical Trial Update: A Prospective Observational Study of Clinical Outcomes for the NanoString® Technologies Prosigna Gene Signature Assay

View source ↗

Summary

This clinical trial update reports a prospective observational study evaluating clinical outcomes associated with the Prosigna gene signature assay by NanoStrin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: NanoString Technologies, Inc. | Conditions: Breast Cancer | Status: COMPLETED